| 产品详情 |
| Edit |   |
| Product Name | THZ1 |
| Description | Purity >95%. THZ1 is a Cdk7 inhibitor (IC50 s = 3.2-15.6 nM in vitro ) that selectively targets a remote cysteine residue located outside of the classic kinase domain. THZ1 also targets Cdk12 kinase activity although at a higher concentration (IC50 = 250 nM). It displays broad anti-proliferative activity against cancer cell lines, particularly T-ALL cell lines that display characteristic misregulation of T cell lineage-specific transcription factors. THZ1 is reported to induce apoptotic cell death in triple-negative breast cancer cells that are highly dependent on Cdk7. |
| Size | n/a |
| Concentration | n/a |
| Applications | n/a |
| Other Names | N-[3-[[5-chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-benzamide |
| Gene, Accession, CAS # | CAS: 1604810-83-4 |
| Catalog # | LS-H10215 |
| Price | |
| Order / More Info | THZ1 from LIFESPAN BIOSCIENCES INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|